Abstract
No additional benefit of slowing progression of hypertensive nephrosclerosis was observed with the lower BP goal. Angiotensin-converting enzyme inhibitors appear to be more effective than beta-blockers or dihydropyridine calcium channel blockers in slowing GFR decline.
Keywords
MedicineRamiprilAmlodipineBlood pressureRenal functionCalcium channel blockerInternal medicineACE inhibitorUrologyMetoprololCardiologyLisinoprilPlaceboKidney diseaseAngiotensin-converting enzyme
Affiliated Institutions
Related Publications
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...
Publication Info
- Year
- 2002
- Type
- article
- Volume
- 288
- Issue
- 19
- Pages
- 2421-2421
- Citations
- 2027
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2027
OpenAlex
Cite This
Jackson T. Wright
(2002).
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>.
JAMA
, 288
(19)
, 2421-2421.
https://doi.org/10.1001/jama.288.19.2421
Identifiers
- DOI
- 10.1001/jama.288.19.2421